S 1618

  • New York Senate Bill
  • 2025 Regular Session
  • Introduced in Senate
  • Passed Senate May 20, 2025
  • Assembly
  • Governor

Enacts the "New York affordable drug manufacturing act"

Abstract

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

Bill Sponsors (6)

Votes


Actions


May 20, 2025

Senate

PASSED SENATE

Assembly

REFERRED TO HEALTH

  • Referral-Committee
HEALTH

Senate

DELIVERED TO ASSEMBLY

May 01, 2025

Senate

ADVANCED TO THIRD READING

Apr 30, 2025

Senate

2ND REPORT CAL.

Apr 29, 2025

Senate

1ST REPORT CAL.750

Jan 21, 2025

Senate

REPORTED AND COMMITTED TO FINANCE

Jan 13, 2025

Senate

REFERRED TO HEALTH

  • Referral-Committee
HEALTH

Bill Text

Bill Text Versions Format
S1618 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.